Clinic
Ascension Medical Group Via Christi, PA
Ascension Medical Group Via Christi, PA was paid $21.27M by Medicaid between Jan 2018 and Dec 2024, across 194 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoASCENSION MEDICAL GROUP VIA CHRISTI, PA
WICHITA, KS 67208
WICHITA, KS 67208
33aNPI1063453991assigned 06/10/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$21.27M
24GClaims554,866
24DCodes billed194
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Kansas
Rank by total paid#1 of 11
Median peer was paid$15K
This provider vs. median1,423×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,213 | $2.84M | |
| 2019 | 93,938 | $3.44M | |
| 2020 | 75,961 | $2.63M | |
| 2021 | 79,224 | $2.96M | |
| 2022 | 96,744 | $3.72M | |
| 2023 | 78,290 | $3.38M | |
| 2024incomplete | 49,496 | $2.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 150,992 | 142,556 | $4.60M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 75,812 | 71,756 | $3.31M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.3% | 16,447 | 15,457 | $1.12M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.2% | 11,906 | 11,612 | $1.11M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.0% | 15,041 | 14,689 | $1.07M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.4% | 37,347 | 11,804 | $946K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.0% | 17,396 | 16,672 | $855K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.6% | 3,168 | 3,047 | $558K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.5% | 7,189 | 7,098 | $541K |
| 99223 | Prolong inpt eval add15 m | 1.9% | 4,782 | 4,419 | $402K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.8% | 1,238 | 1,204 | $390K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.6% | 5,492 | 4,722 | $333K |
182 more codes
| 76819 | Fetal biophysical profile; without non-stress testing | 1.4% | 4,361 | $306K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 15,429 | $304K |
| J2357 | Injection, omalizumab, 5 mg | 1.4% | 209 | $291K |
| 99203 | Doctor's office visit, new patient (routine) | 1.3% | 5,452 | $283K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.3% | 8,222 | $272K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.2% | 4,865 | $261K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.2% | 8,100 | $258K |
| 76801 | 1.2% | 2,592 | $252K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 1.2% | 5,215 | $252K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.2% | 2,393 | $248K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.1% | 393 | $227K |
| 99239 | Hospital discharge day management, more than 30 minutes | 1.0% | 3,912 | $217K |
| 99460 | <1% | 3,321 | $210K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,726 | $208K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,269 | $204K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,418 | $194K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 1,123 | $177K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 19,555 | $151K |
| 95720 | <1% | 1,838 | $130K | |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 104 | $127K |
| 92567 | <1% | 8,224 | $122K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,224 | $105K |
| 76813 | <1% | 844 | $75K | |
| 95951 | <1% | 670 | $73K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,229 | $68K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 312 | $68K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 3,467 | $67K |
| 31231 | <1% | 706 | $67K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 982 | $66K |
| 90677 | <1% | 905 | $40K | |
| 94010 | <1% | 1,886 | $38K | |
| 95819 | <1% | 306 | $29K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 810 | $28K |
| 93000 | <1% | 2,023 | $24K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 275 | $23K |
| 90474 | <1% | 1,155 | $23K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 234 | $21K |
| 95816 | <1% | 491 | $21K | |
| 99285 | Emergency room visit (most serious) | <1% | 288 | $19K |
| 90837 | Psychotherapy session, about an hour | <1% | 238 | $19K |
| 99318 | <1% | 871 | $18K | |
| 76642 | <1% | 694 | $17K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,985 | $17K |
| 00126 | <1% | 146 | $15K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 945 | $15K |
| 88342 | <1% | 508 | $15K | |
| 54150 | <1% | 111 | $15K | |
| 99337 | <1% | 969 | $14K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 421 | $13K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 199 | $12K |
| 93298 | <1% | 969 | $12K | |
| 31575 | <1% | 220 | $12K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 32 | $12K |
| 95117 | <1% | 875 | $11K | |
| 64615 | <1% | 175 | $10K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 64 | $10K |
| 90686 | <1% | 7,880 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 690 | $10K |
| 97802 | <1% | 551 | $9K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,015 | $9K |
| 92587 | <1% | 200 | $9K | |
| 99462 | <1% | 567 | $8K | |
| 99220 | <1% | 91 | $8K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 115 | $8K |
| 93296 | <1% | 743 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 375 | $7K |
| 88304 | <1% | 310 | $7K | |
| 95970 | <1% | 555 | $7K | |
| 51798 | <1% | 951 | $6K | |
| 99383 | <1% | 105 | $6K | |
| 92555 | <1% | 479 | $6K | |
| 94060 | <1% | 150 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 921 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 526 | $5K |
| 92588 | <1% | 74 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 46 | $4K |
| 76820 | <1% | 67 | $4K | |
| 92504 | <1% | 322 | $4K | |
| 92552 | <1% | 264 | $4K | |
| 99225 | <1% | 171 | $4K | |
| 99217 | <1% | 112 | $4K | |
| 94729 | <1% | 311 | $4K | |
| 99236 | Prolong inpt eval add15 m | <1% | 32 | $4K |
| 95974 | <1% | 72 | $3K | |
| 99284 | Emergency room visit (serious) | <1% | 49 | $3K |
| 77066 | Tomosynthesis, mammo | <1% | 105 | $3K |
| 99336 | <1% | 366 | $3K | |
| 64642 | <1% | 89 | $3K | |
| 94726 | <1% | 200 | $3K | |
| 71271 | <1% | 103 | $3K | |
| 93015 | <1% | 83 | $3K | |
| 95811 | <1% | 15 | $3K | |
| 99283 | Emergency room visit (moderate) | <1% | 86 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 133 | $3K |
| 64643 | <1% | 70 | $2K | |
| 93295 | <1% | 115 | $2K | |
| 69210 | <1% | 108 | $2K | |
| 99305 | <1% | 199 | $2K | |
| 90715 | <1% | 253 | $2K | |
| 73030 | <1% | 297 | $2K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 241 | $2K |
| 92557 | <1% | 57 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 132 | $2K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 23 | $2K |
| 20610 | <1% | 45 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 99 | $1K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 216 | $1K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 25 | $1K |
| 95910 | <1% | 13 | $1K | |
| 99382 | <1% | 25 | $1K | |
| 81003 | <1% | 1,280 | $1K | |
| 99304 | <1% | 128 | $967.02 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 131 | $937.80 |
| 90670 | <1% | 10,035 | $774.65 | |
| 99381 | <1% | 13 | $721.00 | |
| 92551 | <1% | 45 | $606.60 | |
| 17110 | <1% | 13 | $568.68 | |
| 93297 | <1% | 74 | $542.99 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 17 | $465.96 |
| 90651 | <1% | 241 | $426.12 | |
| 95886 | <1% | 15 | $392.58 | |
| 90661 | <1% | 31 | $345.37 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13 | $300.24 |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $290.59 |
| 95977 | <1% | 27 | $271.77 | |
| 92553 | <1% | 13 | $259.20 | |
| 99070 | <1% | 122 | $255.01 | |
| 93294 | <1% | 58 | $241.92 | |
| 81002 | <1% | 113 | $203.24 | |
| 95885 | <1% | 15 | $196.56 | |
| 77062 | <1% | 16 | $140.13 | |
| 90647 | <1% | 7,490 | $134.24 | |
| 90734 | <1% | 705 | $126.50 | |
| 90716 | <1% | 748 | $124.46 | |
| 74018 | <1% | 12 | $122.69 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 14 | $115.29 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $91.80 |
| 99335 | <1% | 15 | $90.61 | |
| 73630 | <1% | 15 | $84.01 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,014 | $68.42 |
| 99173 | <1% | 14 | $63.47 | |
| 82947 | <1% | 21 | $46.52 | |
| 90461 | <1% | 5,805 | $43.20 | |
| J3490 | Unclassified drugs | <1% | 34 | $36.84 |
| A4314 | Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) | <1% | 14 | $19.68 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 15 | $12.08 |
| 98926 | <1% | 34 | $8.88 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 185 | $5.60 |
| A4358 | Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each | <1% | 14 | $5.16 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 26 | $4.86 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 51 | $3.83 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 16 | $3.42 |
| G0008 | Administration of influenza virus vaccine | <1% | 144 | $0.10 |
| 90723 | <1% | 7,578 | $0.10 | |
| 90680 | <1% | 5,583 | $0.10 | |
| 99000 | 0% | 563 | $0.00 | |
| 90696 | 0% | 410 | $0.00 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 63 | $0.00 |
| 90634 | 0% | 390 | $0.00 | |
| 90656 | 0% | 297 | $0.00 | |
| 3074F | 0% | 82 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 13 | $0.00 |
| 3079F | 0% | 36 | $0.00 | |
| 1036F | 0% | 47 | $0.00 | |
| 3044F | 0% | 12 | $0.00 | |
| 3008F | 0% | 15 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 13 | $0.00 |
| 0001A | 0% | 13 | $0.00 | |
| 90700 | 0% | 716 | $0.00 | |
| 90710 | 0% | 696 | $0.00 | |
| 90633 | 0% | 3,450 | $0.00 | |
| 90707 | 0% | 802 | $0.00 | |
| 90685 | 0% | 295 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 48 | $0.00 |
| 90681 | 0% | 133 | $0.00 | |
| 3078F | 0% | 77 | $0.00 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 17 | $0.00 |
| 90648 | 0% | 14 | $0.00 | |
| 0002A | 0% | 16 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 45 | $0.00 |
| 1159F | 0% | 13 | $0.00 | |
| 1160F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWRIGHT, SUZANN (DIRECTOR,PATIENT FINANCIAL SERVICES)
| Provider | Location | Paid |
|---|---|---|
| Ascension Medical Group Via Christi, PA | Wellington, KS | $424K |
| Ascension Medical Group Via Christi, PA | Wichita, KS | $268K |
| Ascension Medical Group Via Christi, PA | Mulvane, KS | $74K |
| Via Christi Clinic, PA | Newton, KS | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.